PDE4B (Rat) Assay Kit
The Rat PDE4B Assay Kit is a fluorescence polarization (FP), homogeneous 96-well assay designed for the screening and profiling of rat PDE4B inhibitors. The kit contains enough purified recombinant rat PDE4B, fluorescent probe (cAMP), PDE Assay Buffer, Binding Agent, and diluent for 100 reactions. This assay requires a fluorescent microplate reader capable of measuring fluorescence polarization (FP) to read the FP signal. For more information on the principles of FP, visit fp_assays.pdf (bpsbioscience.com).
Figure 1: Illustration of the PDE4B assay principle.
The assay uses a fluorescein-labeled cyclic adenosine monophosphate (cAMP-FAM), in which the phosphate group is engaged within the cyclic nucleotide. This is a very small molecule that can rotate fast (low FP). PDE4B catalyzes the hydrolysis of the phosphodiester bond in the cyclic nucleotide and frees the phosphate group. In a second step the free phosphate group is recognized by a specific phosphate-binding nanobead (Binding Agent) leading to the formation of large complex, with restricted movement (high FP). FP values are proportional to PDE activity.
Need us to run inhibitor screens or profile your compounds against PDE4B (Rat)? Check out our Phosphodiesterase Screening Services.
Fluorescent plate reader capable of measuring fluorescence polarization.
| Catalog # | Name | Amount | Storage |
| 60049 | Rat PDE4B, GST-Tag* | 1 µg | -80°C |
| 60200 | 20 µM FAM-Cyclic-3′, 5′-AMP | 50 µl | -80°C |
| 60393 | PDE Assay Buffer | 25 ml | -20°C |
| 60390 | Binding Agent | 100 µl | 4°C |
| 60391 | cAMP Binding Agent Diluent | 10 ml | 4°C |
| 0.5 M DTT | 100 µl | -80°C | |
| 79685 | Low binding, black 96-well plate | 1 | Room Temp |
* The concentration of protein is lot-specific and will be indicated on the tube containing the protein.
PDE4B, also known as cAMP-specific 3’.5’-cyclic phosphodiesterase 4B, is a protein of the PDE (cyclic nucleotide phosphodiesterase) family. cGMP and cAMP are second messengers in responses to several signals, such as hormones and neurotransmitters. By hydrolyzing cyclic nucleotides, PDEs regulate multiple pathways. PDE4B hydrolizes cAMP, and its dysfunction is involved in schizophrenia, bipolar disease, and psoriasis. It is also involved in neutrophil and microvascular obstruction in acute myocardial infarction. Inhibitors of PDE4B have been shown to have antipsychotic effects and protect against myocardial ischemia reperfusion (MI/R) injury.
1. Clapcote SJ, et al., Adv Neurobiol. 2017;17:103-131.
2. Braun, N.N., et al., NeuroReport. 2007; Nov; 18(17):1841-1844.
Powered by Bioz
San Diego, CA 92121
858-202-1401
Products are for Research Use Only
COMPANY
Copyright © 2024
BPS Bioscience, Inc.
All rights reserved.
Diagrams on this website are created with BioRender.com.